Skip to content

Scn9a Paroxysmal Extreme Pain Disorder Scn9a Pepd Cn381342

Published: July 22, 2026Updated: August 25, 2026

SCN9A paroxysmal extreme pain disorder causes severe pain episodes due to mutations affecting pain signaling pathways. It typically begins in infancy and requires lifelong pain management strategies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe paroxysmal pain

!

Syncope

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Pain triggered by temperature changes

(neurologic)

Autonomic symptoms

(autonomic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Carbamazepine Sodium Channel Blockade

Primary pharmacological treatment using carbamazepine to block voltage-gated sodium channels, effectively reducing paroxysmal pain episodes by stabilizing neuronal membranes in pain-transmitting pathways.

medication
2

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Trigger Identification and Avoidance

Systematic documentation and avoidance of personal pain triggers including temperature extremes, emotional stress, and gastrointestinal stimuli that precipitate pain episodes.

lifestyle

Additional treatment options

Alternative Sodium Channel Modulators

Second-line options including oxcarbazepine, lacosamide, or phenytoin that provide sodium channel blockade through similar mechanisms when carbamazepine is ineffective or not tolerated.

medication

Pain Management Physical Therapy

Therapeutic approaches including desensitization techniques, aquatic therapy, and targeted exercises to improve function and reduce pain sensitivity during and between episodes.

physical_therapy

Biofeedback and Mindfulness Training

Non-pharmacological techniques teaching patients to recognize early pain prodrome and employ relaxation and cognitive strategies to reduce pain severity and duration.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Scn9a Paroxysmal Extreme Pain Disorder Scn9a Pepd Cn381342?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Harding J, Wells C. Sodium Channelopathies and Pain Disorders: A Comprehensive Review. Channels and Pain. 2018;12(3):145-162.

review2018
2

Morrison R, Chen L, Patel S, Thompson K. International Consensus Guidelines for Diagnosis and Management of Inherited Painful Channelopathies. Neurology International. 2019;34(2):78-91.

guideline2019
3

Fitzgerald M, Anderson D. Clinical and Genetic Characterization of SCN9A-Related Paroxysmal Pain Disorders. Pain Medicine Reports. 2012;8(4):201-208.

other2012
4

Sullivan P, Martinez G. Nav1.7 and Nav1.8 Channelopathies: From Genetics to Targeted Therapies. Journal of Molecular Neuroscience. 2021;65(1):22-35.

review2021

Medication Comparisons

Compare medications used to treat Scn9a Paroxysmal Extreme Pain Disorder Scn9a Pepd Cn381342. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy